insights_auto
Why is HLNCF down 2.16%?
Dive Deeperchevron_right
HLNCF:OTCMKTS
Haleon PLC
$4.54
arrow_downward
-2.16%(-0.100) 1D
Sep 24, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HLNCF...
Open
$4.53
High
$4.54
Low
$4.53
Mkt. cap
40.57B
Avg. vol.
5.24K
Volume
1.54K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.89
Shares outstanding
8.80B
No. of employees
25K
Open
$4.53
High
$4.54
Low
$4.53
Mkt. cap
40.57B
Avg. vol.
5.24K
Volume
1.54K
52-wk high
$5.75
52-wk low
$4.15
Beta
-21.89
Shares outstanding
8.80B
No. of employees
25K
News stories
From web sources and news partners
Stock Titan
·
11 hours ago
Haleon (HLN) reports dividend-reinvestment share acquisitions by Dawn Allen and Brian McNamara.
TipRanks
·
12 hours ago
Haleon Executives Boost Holdings Through Dividend Reinvestment
AskTraders
·
1 day ago
Jefferies Trims Haleon Share Price Target, Keeps Buy Rating Ahead of Results
AD HOC NEWS
·
2 days ago
Haleon stock gains as GLP-1 strategy lifts US sales
Profile
Haleon plc is a British multinational consumer healthcare company with headquarters in Weybridge, England. It is one of the largest consumer healthcare businesses in the world, with brands including Sensodyne toothpaste, Panadol and Advil painkillers, and Centrum vitamins. The company was projected to be a global leader in over the counter medicines with a 7.3 per cent market share in 2022.
Haleon was established on 18 July 2022 as a corporate spin-off from GSK. Haleon is listed on the London Stock Exchange and is a component of the FTSE 100, with a secondary listing on the New York Stock Exchange. Wikipedia
About Haleon PLC